187.22
1.28%
-2.42
Dopo l'orario di chiusura:
187.22
Icon Plc Borsa (ICLR) Ultime notizie
Prudential expands preferred healthcare network in partnership with Icon Cancer Centre - Media OutReach
ICON Plc stock hits 52-week low at $208.38 amid market shifts - Investing.com India
ICON to Present at London Healthcare Conference - TipRanks
ICON plc to Present at the Jefferies London Healthcare Conference - Yahoo Finance
RNA Therapy Clinical Trials Market Size, Scope and Growth to 2031 - InsightAce Analytic
Rose Kidd, ICON – Winner of WMB Businesswoman Award 2024 - Women Mean Business
Icon PLC (ICLR) Shares Up 3.48% on Nov 6 - GuruFocus.com
Life Sciences BPO Market Set to Witness Significant Growth by 2024-2031:Catalent, Inc., Covance, Inc., Fareva, - EIN News
Icon (FRA:IJF) GF Value Rank : 10 (As of Nov. 04, 2024) - GuruFocus.com
ICON Plc stock touches 52-week low at $219.87 amid market shifts - Investing.com Australia
Icon PLC (ICLR) Trading 3.72% Higher on Oct 2 - GuruFocus.com
ICLR Misses on Q3 Earnings, Lowers 2024 Guidance, Stock Falls - Yahoo Finance
ICON's $650 Million Power Play: Can This Bold Move Reverse a 21% Stock Plunge? - Yahoo Finance UK
Baird Downgrades ICON Public Limited (ICLR) - MSN
Icon plc Strengthens Investor Confidence with Secured Notes - TipRanks
Earnings call: ICON PLC faces headwinds, eyes strategic growth By Investing.com - Investing.com Australia
Earnings call: ICON PLC faces headwinds, eyes strategic growth - Investing.com India
Icon Earnings: Shares Tank as Elevated Cancellations Reduce 2024 Guidance - Morningstar
Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Pharmaceutical Contract Sales Outsourcing (CSO) Market Projected To Witness Substantial Growth, 2024-2031: - EIN News
Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Cha - GuruFocus.com
ICON Plc stock touches 52-week low at $227.56 amid market shifts - Investing.com Australia
U.S. Markets Finished Mixed Thursday As Tesla Led, Icon PLC Lagged - Barron's
ICON stock slips after guidance cut (ICLR:NASDAQ) - Seeking Alpha
Icon PLC Down Over 19%, on Pace for Largest Percent Decrease Since March 1999 — Data Talk - Morningstar
ICON Plc stock touches 52-week low at $227.56 amid market shifts By Investing.com - Investing.com South Africa
Icon shares maintain Outperform rating with Leerink despite market pressures - Investing.com
Baird downgrades ICON plc stock, slashes outlook on lower earnings and revenue guidance - Investing.com
S&P 500 Futures Up in Premarket Trading; Icon PLC, Darling Ingredients Lag - Barron's
ICON revenue slumps 1.2% to USD 2,030M in Q3 2024 - Medical Buyer
Icon PLC: Q3 Earnings Snapshot - Houston Chronicle
Icon PLC (ICLR) Lags Q3 Earnings and Revenue Estimates - Yahoo Finance
ICON Reports Third Quarter 2024 Results - sharewise
ICON Reports Mixed Q3 Results, Secures Key Partnership - TipRanks
Icon PLC: Q3 Earnings Snapshot | National Business News | voiceofalexandria.com - Voice Of Alexandria
ICON plc shares tumble as Q3 results miss estimates, guidance cut - Investing.com Australia
ICON plc shares tumble as Q3 results miss estimates, guidance cut By Investing.com - Investing.com South Africa
Imaging CRO Market Is Booming Worldwide 2025-2030 | WORLDCARE - openPR
Icon PLC (ICLR) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Randomization and Trial Supply Management Market 2024-2031- Calyx, Almac, ICON plc, Trialogics, IBM, Medpace CRO, Endpoi – IndiaPolitics.com - IndiaPolitics.com
Redburn Atlantic Initiates Coverage of ICON Public Limited (ICLR) with Neutral Recommendation - Nasdaq
ICON plc stock faces Neutral rating as analyst flags downside risk to growth projections - Investing.com Australia
Biomarker Research Services Market Synopsis: Trends, Industry Insights, and Growth Forecast 2024-2031 |BioIVT, - EIN News
Onco-hematology Molecular Testing Market Size to Reach USD 1.5 billion by 2031 with a 12.5% CAGR, Boosted by Next-Generation Blood Cancer Diagnostics| Exclusive Report by Transparency Market Research, Inc. - GlobeNewswire Inc.
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):